These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17471023)

  • 1. Daxx shortens mitotic arrest caused by paclitaxel.
    Lindsay CR; Scholz A; Morozov VM; Ishov AM
    Cell Cycle; 2007 May; 6(10):1200-4. PubMed ID: 17471023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of mitosis and taxane response by Daxx and Rassf1.
    Giovinazzi S; Lindsay CR; Morozov VM; Escobar-Cabrera E; Summers MK; Han HS; McIntosh LP; Ishov AM
    Oncogene; 2012 Jan; 31(1):13-26. PubMed ID: 21643015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinase.
    Giovinazzi S; Morozov VM; Summers MK; Reinhold WC; Ishov AM
    Cell Death Differ; 2013 May; 20(5):721-31. PubMed ID: 23348568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance.
    Pan WW; Zhou JJ; Liu XM; Xu Y; Guo LJ; Yu C; Shi QH; Fan HY
    J Biol Chem; 2013 May; 288(19):13620-30. PubMed ID: 23539629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest.
    Kang S; Kang D; Bakhtiar Ul Islam SM; Je S; Kim JH; Song JJ
    Cell Signal; 2015 Jun; 27(6):1214-24. PubMed ID: 25748050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daxx regulates mitotic progression and prostate cancer predisposition.
    Kwan PS; Lau CC; Chiu YT; Man C; Liu J; Tang KD; Wong YC; Ling MT
    Carcinogenesis; 2013 Apr; 34(4):750-9. PubMed ID: 23239745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
    Ling YH; Jiang JD; Holland JF; Perez-Soler R
    Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP.
    Lai H; Wang R; Li S; Shi Q; Cai Z; Li Y; Liu Y
    Sci China Life Sci; 2020 Mar; 63(3):419-428. PubMed ID: 31420851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of new intraperitoneal paclitaxel-resistant gastric cancer cell lines and comprehensive gene expression analysis.
    Murakami H; Ito S; Tanaka H; Kondo E; Kodera Y; Nakanishi H
    Anticancer Res; 2013 Oct; 33(10):4299-307. PubMed ID: 24122996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.
    Benitez JA; Ma J; D'Antonio M; Boyer A; Camargo MF; Zanca C; Kelly S; Khodadadi-Jamayran A; Jameson NM; Andersen M; Miletic H; Saberi S; Frazer KA; Cavenee WK; Furnari FB
    Nat Commun; 2017 May; 8():15223. PubMed ID: 28497778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
    Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A
    Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daxx inhibits stress-induced apoptosis in cardiac myocytes.
    Zobalova R; Swettenham E; Chladova J; Dong LF; Neuzil J
    Redox Rep; 2008; 13(6):263-70. PubMed ID: 19017466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-apoptotic effects of probucol are associated with downregulation of Daxx expression in THP-1 macrophage.
    Su B; Yang YB; Tuo QH; Zhu BY; Lei XY; Yin W; Liao DF
    Cardiovasc Drugs Ther; 2007 Feb; 21(1):37-45. PubMed ID: 17370120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daxx interacts with and modulates the activity of CREB.
    Huang YS; Chang CC; Huang TC; Hsieh YL; Shih HM
    Cell Cycle; 2012 Jan; 11(1):99-108. PubMed ID: 22185778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells.
    Lee EA; Keutmann MK; Dowling ML; Harris E; Chan G; Kao GD
    Mol Cancer Ther; 2004 Jun; 3(6):661-9. PubMed ID: 15210851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.
    Sui M; Huang Y; Park BH; Davidson NE; Fan W
    Cancer Res; 2007 Jun; 67(11):5337-44. PubMed ID: 17545614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daxx represses expression of a subset of antiapoptotic genes regulated by nuclear factor-kappaB.
    Croxton R; Puto LA; de Belle I; Thomas M; Torii S; Hanaii F; Cuddy M; Reed JC
    Cancer Res; 2006 Sep; 66(18):9026-35. PubMed ID: 16982744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bim is reversibly phosphorylated but plays a limited role in paclitaxel cytotoxicity of breast cancer cell lines.
    Czernick M; Rieger A; Goping IS
    Biochem Biophys Res Commun; 2009 Jan; 379(1):145-50. PubMed ID: 19101511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis.
    Lin CW; Wang LK; Wang SP; Chang YL; Wu YY; Chen HY; Hsiao TH; Lai WY; Lu HH; Chang YH; Yang SC; Lin MW; Chen CY; Hong TM; Yang PC
    Nat Commun; 2016 Dec; 7():13867. PubMed ID: 28004751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
    Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
    Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.